0000950170-24-073063.txt : 20240613
0000950170-24-073063.hdr.sgml : 20240613
20240613163012
ACCESSION NUMBER: 0000950170-24-073063
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240612
FILED AS OF DATE: 20240613
DATE AS OF CHANGE: 20240613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Skvarka Jan
CENTRAL INDEX KEY: 0001838042
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40522
FILM NUMBER: 241041657
MAIL ADDRESS:
STREET 1: C/O TRILLIUM THERAPEUTICS INC.
STREET 2: 2488 DUNWIN DRIVE
CITY: MISSISSAUGA
STATE: A6
ZIP: L5L 1J9
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monte Rosa Therapeutics, Inc.
CENTRAL INDEX KEY: 0001826457
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 HARRISON AVENUE
STREET 2: SUITE 900
CITY: BOSTON
STATE: MA
ZIP: 02118
BUSINESS PHONE: 617-949-2643
MAIL ADDRESS:
STREET 1: 321 HARRISON AVENUE
STREET 2: SUITE 900
CITY: BOSTON
STATE: MA
ZIP: 02118
4
1
ownership.xml
4
X0508
4
2024-06-12
0001826457
Monte Rosa Therapeutics, Inc.
GLUE
0001838042
Skvarka Jan
MONTE ROSA THERAPEUTICS, INC.
321 HARRISON AVENUE, SUITE 900
BOSTON
MA
02118
true
false
false
false
false
Stock Option (Right to Buy)
4.16
2024-06-12
4
A
false
22100
0
A
2034-06-12
Common Stock
22100
22100
D
The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 12, 2025 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time.
/s/ Markus Warmuth, Attorney-in-Fact
2024-06-13